ai3Bio
ai3Bio develops treatments to transform the lives of patients with cancer.
$48M Series A ·
Led by UPMC Enterprises · Source: ai3.bio
Funding history ↓Signals
Website registeredJan 28, 2026 (10 months old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $48M | ai3.bio |
Timeline
- Website created
Founders and team
DV
Dario Vignali FounderGD
Greg Delgoffe FounderRF
Robert Ferris Founder
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| CCorner Therapeutics - Autoimmune Division | Not disclosed publicly |
Investors
Companies like ai3Bio
SSyantra$3.6M Series A · Sep 2024
SSkribe Medical$1.65M Pre Seed · Nov 2026
AAlethio Therapeutics$90M Series A · Nov 2026
DDren Bio$350M Series B+ · Oct 2026SSmartinBio$150.9K · Oct 2026
OOna Therapeutics$86.6M Series B+ · Oct 2026
Other companies backed by UPMC Enterprises
EEstuary Biotherapeutics$103M Series A · Oct 2026
BBrainCheck$13M Series B+ · Feb 2026
PPrecede$83.5M Series B+ · Jan 2026
PPercipio$16M Series A · Dec 2025
KKoda Health$7M Series A · Oct 2025
UUltromics$55M Series B+ · Aug 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ai3bio (get a free API key).